查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球蛋白质体学市场，到 2030 年的预测：按产品、服务和软体、技术、应用、最终用户和地区进行的全球分析
市场调查报告书
商品编码
1372045

全球蛋白质体学市场，到 2030 年的预测：按产品、服务和软体、技术、应用、最终用户和地区进行的全球分析

Proteomics Market Forecasts to 2030 - Global Analysis By Product, Services & Software,Technology, Application, End User, and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球蛋白质体学市场规模为 522.8 亿美元，预计到 2030 年将达到 1,155.7 亿美元，预测期内年复合成长率为 12.0%。

生物技术的领域称为蛋白质组学，它使用分子生物学、生物化学和遗传学技术来检查特定细胞、组织和生物体产生的蛋白质的结构、功能和相互作用，并将资讯编译到资料库中。它被定义为组织并应用资料。蛋白质体学可以分为各种子类别，例如结构蛋白质体学、功能蛋白质体学和表达蛋白质体学。蛋白质体学能够鑑定越来越多的蛋白质。这随着时间、具体要求或细胞或生物体所承受的压力而改变。

据 Globocan 称，2020 年 12 月，全球报告了 1,930 万新癌症病例和 1,000 万癌症相关死亡。同样，CVD也是全世界死亡的主要原因之一。例如，根据世界卫生组织（2021）的数据，年度有 4,100 万名患者死于目标疾病。

奈米蛋白质体学的使用增加和慢性病的增加

许多蛋白质体学应用都与奈米技术相关，包括磷酸化蛋白质体学/金属氧化物奈米粒子、用于蛋白质分离的奈米结构表面以及用于生物标记和蛋白质分析检测的阵列技术。由于蛋白质体学技术应用于奈米技术，奈米蛋白质体学已成为研究领域。透过奈米多孔结构、功能化奈米粒子、量子点和聚合物奈米结构等众多奈米技术应用，此技术被用作彻底改变蛋白质体学的辅助手段。因此，对个体化治疗的需求以及危及生命的疾病的流行预计将使该行业在预测期内受益。

设备和试剂高成本

上市公司使用公开的结构资料和试验技术来获得刺激或抑制目标蛋白质的物质。蛋白质结构的研究需要使用高通量设备。使用 X 射线结晶的蛋白质组学经常涉及基因克隆、蛋白质表现、蛋白质精製和蛋白质结晶。所有这些过程都需要大量的实验室时间，这提高了每个样品的测试价格。此外，由于设备和消耗品成本高昂，开发中国家难以进入蛋白质体学领域。预计这些因素将阻碍市场扩张。

蛋白质体学的技术进步

这些技术显着提高灵敏度和分辨率，实现高通量和多重分析，促进资料整合，改进样品製备和分级分离技术，实现基于质谱的成像，并提供先进的资料分析和资讯学工具。进步彻底改变了蛋白质体学领域。这些技术开拓使人们能够全面彻底地了解蛋白质组，对于推动市场扩张至关重要。此外，这些技术的发展正在扩大蛋白质体学研究的范围，使人们能够对各种生物环境中的蛋白质进行彻底而详细的研究，从而刺激市场扩张。

技术复杂且缺乏标准化

蛋白质体学市场的成长可能会受到技术复杂性、资料分析困难和标准化问题的阻碍。蛋白质体学研究中使用的复杂技术和方法需要专门的知识和技能。蛋白质体学资料分析和结果解释很困难，需要生物资讯学和资料分析的专业知识。分析和解释从蛋白质体学实验中获得的大量资料可能很困难。此外，由于缺乏标准化实践以及需要强大的资料分析管道，市场扩张可能会遇到困难和障碍。

COVID-19 的影响

蛋白质体学服务受益于 COVID-19大流行，市场成长正在加速。我们观察到，与先前的支出相比，许多公司减少了临床试验的研发支出，这显示了疫情影响的严重性。此外，新的临床试验技术和模型的兴起，例如 CRO 使用技术先进的质谱仪来获得高品质的结果，导致了快速临床试验的报告。由于这些特点，蛋白质体学产业拥有强大的发展机会。

药物研发领域预计在预测期内规模最大

据估计，药物研发领域在预测期内是最大的。该行业的扩张得益于基于结构的药物设计的进步、对个体化药物开发的重视以及这些领域资金筹措的增加。此外，蛋白质体学技术还提供了一种在药物研发过程阶段展示药物潜力的机制，为製药公司节省了大量资金，并最终帮助患者和医疗保健系统，这支持了该领域的扩展。

在预测期内，光谱学领域预计将出现最高的年复合成长率。

预计光谱领域在预测期内年复合成长率最高。蛋白质体学研究主要依赖光谱学，光谱学也常用于分析蛋白质及其结构特性。这使得蛋白质能够被识别、检测和表征，提供有关它们的作用、相互作用和变化的重要细节。此外，光谱技术和资料分析工具的不断进步进一步扩大了光谱学在蛋白质组学市场中的能力和应用。

比最大的地区

预计亚太地区在预测期内将占据最大份额。该地区蛋白质组学行业的扩张得益于该地区製药公司的存在以及中国和印度等国家老年人口的不断增长。此外，随着个人化医疗需求的增加，对药物研发的需求也在增加，而生物技术产业新兴市场的开拓正在刺激该地区的市场扩张。亚太地区拥有最大的製药业，并且拥有丰富的技术先进的医疗设备，蛋白质体学产品的生产商可以轻鬆获得这些设备。

复合年复合成长率最高的地区

北美在整个主导时期排名最高，因为它专注于基于结构的药物设计的开发、组学研究的发展、对资料可重复性的高品质研究工具的渴望以及个体化治疗方法的开发。显示出年复合成长率。该地区重要公司之间的联盟与合作也促进了该行业的扩张。此外，为了加速复杂治疗性蛋白质的特性和品质监测，Thermo Fisher Scientific Inc. 和 Symphogen 开发了经过验证的平台流程。

免费客製化服务

订阅此报告的客户可以利用以下免费自订选项之一：

  • 公司简介
    • 其他市场公司的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和年复合成长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第1章执行摘要

第2章前言

  • 概述
  • 利害关係人
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究来源
    • 主要研究来源
    • 二次研究来源
    • 先决条件

第3章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第5章全球蛋白质体市场：副产品

  • 试剂/消耗品
  • 装置
  • 服务

第6章全球蛋白质体市场：依服务和软体分类

  • 核心蛋白质体学服务
    • 蛋白质表征服务
    • 蛋白质鑑定服务
    • 蛋白质精製服务
    • 定量蛋白质体学服务
    • 蛋白质序列测定服务
    • 蛋白质分离服务
    • 客製化验服务
  • 生物资讯服务和软体
    • 生物资讯学工具
    • 生物资讯服务
    • 生物资讯资料库

第7章全球蛋白质体学市场：依技术分类

  • 光谱学
    • 质谱
  • 核磁共振波谱
    • 圆二色光谱
  • 色谱法
    • 高效液相层析
    • 超临界流体层析
    • 亲和层析
    • 离子色谱法
  • 电泳
    • 凝胶电泳
    • 毛细管电泳
  • 蛋白质微阵列
    • 生物晶片
      • 晶片实验室
      • 蛋白质晶片
    • 微阵列装置
      • 整合系统
      • 阵列器
      • 微阵列扫描仪
  • X射线结晶结构分析
  • 表面等离子体共振
  • 蛋白质分级分离
  • 其他技术

第8章全球蛋白质体学市场：依应用分类

  • 临床诊断
    • 感染疾病
    • 癌症
    • 糖尿病
    • 自体免疫疾病
    • 神经系统疾病
    • 心血管疾病
    • 其他临床诊断应用
  • 临床研究
  • 药物研发
    • 目标发现
    • 潜在客户最佳化
    • 线索识别
    • 临床前研究
  • 其他用途

第9章全球蛋白质体学市场：依最终用户分类

  • 实验室
  • 学术/研究机构
  • 医院
  • 製药公司/生物製药公司
  • 其他最终用户

第10章全球蛋白质体市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东/非洲

第11章进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第12章公司简介

  • Agilent Technologies, inc.
  • Illumina, Inc.
  • Ge Healthcare
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • Thermo fisher Scientific, Inc.
  • Promega Corporation
  • F. Hoffmann-La Roche Ltd.
  • Danaher
  • Merck Kgaa.
  • Waters Corporation
  • Caprion Proteomics Inc.
  • Luminex Corporation
  • PerkinElmer, Inc.
  • SomaLogic Operating Co.
  • Olink
Product Code: SMRC24101

According to Stratistics MRC, the Global Proteomics Market is accounted for $52.28 billion in 2023 and is expected to reach $115.57 billion by 2030 growing at a CAGR of 12.0% during the forecast period. The branch of biotechnology known as proteomics is defined as the application of molecular biology, biochemistry, and genetics techniques to the examination of the structure, function, and interactions of the proteins made by a specific cell, tissue, or organism, the organization of the information in databases, and the applications of the data. Proteomics can be categorized into a number of different subcategories, including structural, functional, and expression proteomics. Proteomics enables the identification of ever-increasing numbers of proteins. This varies with time and distinct requirements, or stresses, that a cell or organism undergoes.

According to Globocan, in December 2020, there were 19.3 million new cases of cancer across the world and 10 million cancer-related deaths were reported. Similarly, CVDs are one of the major causes of death worldwide. For instance, as per the WHO (2021), target diseases kill 41 million patients per year.

Market Dynamics:

Driver:

Rising use of nano proteomics and increasing prevalence of chronic illnesses

Many proteomics applications have been linked to nanotechnology, including phosphoproteomics/metal oxide nanoparticles, nanostructured surfaces for protein separation, and array techniques for analytical detection of biomarker proteins. Nanoproteomics has emerged as a field of study as a result of the application of proteomics techniques to nanotechnology. Through numerous nanotechnology applications, including nanoporous structures, functionalized nanoparticles, quantum dots, and polymeric nanostructures, this technique is used as a supporting element to revolutionize proteomics. Thus, the need for personalized therapies, along with the prevalence of life-threatening diseases, is anticipated to benefit the industry throughout the forecast period.

Restraint:

High cost of instruments and reagents

Companies obtain substances that either stimulate or inhibit target proteins using publicly available structural data and trial-and-error techniques. The study of protein structure necessitates the use of high-throughput equipment. Gene cloning, protein expression, protein purification, and protein crystallization are all frequently done in proteomics using X-ray crystallography. These processes all require a significant amount of laboratory time, which drives up the price of testing each sample. Moreover, developing nations struggle to enter the proteomics field due to the high cost of equipment and supplies. Such factors are anticipated to impede market expansion.

Opportunity:

Technological Progress in Proteomics

Technological advances that have greatly increased sensitivity and resolution, permitted high-throughput and multiplexed analysis, facilitated data integration, improved sample preparation and fractionation techniques, permitted mass spectrometry-based imaging, and provided sophisticated data analysis and informatics tools have revolutionized the field of proteomics. By enabling a complete and thorough understanding of the proteome, these developments have been crucial in fostering the market's expansion. Additionally, these technological developments have increased the scope of proteomics research, allowing thorough and in-depth investigation of proteins in a variety of biological contexts, which is fueling market expansion.

Threat:

Technological complexities and lack of standardization

Proteomics market growth may be hampered by technological complexity, data analysis difficulties, and standardization issues. Complex technologies and methodologies used in proteomics research call for specialized knowledge and skills. Proteomic data analysis and result interpretation can be difficult and require expertise in bioinformatics and data analysis. The analysis and interpretation of the enormous amounts of data produced by proteomics experiments can be challenging. Additionally, there may be difficulties and barriers to the market's expansion due to a lack of standardization practices and the requirement for strong data analysis pipelines.

COVID-19 Impact:

The proteomics services have shown to benefit from the COVID-19 pandemic, which has accelerated market growth. A number of businesses were observed to reduce their R&D expenditures for clinical trials in contrast to earlier expenditures, indicating the extent of the pandemic's impact. Additionally, due to the rise of novel clinical trial methodologies or models, which include the use of technologically advanced mass spectrometers by CROs specifically for quality outcomes, rapid clinical trials have been reported. The proteomics industry has strong development opportunities as an outcome of these traits.

The drug discovery segment is expected to be the largest during the forecast period

The drug discovery segment is estimated to be the largest during the extrapolated period. The expansion of this industry can be attributed to the development of structure-based drug design, a greater focus on developing personalized medicines, and increased funding in these fields. Additionally, proteomics technologies also provide a mechanism to demonstrate a medicine's potential early in the drug discovery process, saving pharmaceutical companies a large sum of money and ultimately assisting patients and healthcare systems, which support the segment's expansion.

The Spectroscopy segment is expected to have the highest CAGR during the forecast period

Spectroscopy segment is anticipated to have highest CAGR during the projected period. Proteomics research relies primarily on spectroscopy, which is also commonly used for analyzing proteins and their structural properties. It makes it possible to recognize, measure, and characterize proteins, providing essential details about their roles, interactions, and changes. Additionally, continuous advancements in spectroscopy technologies and data analysis tools are further expanding the capabilities and applications of spectroscopy in the proteomics market.

Region with largest share:

Asia-Pacific is anticipated to have largest share during the forecast period. The expansion of the proteomics industry in this area is due to the presence of pharmaceutical businesses there as well as the rising elderly population in nations like China and India. Additionally, as demand for personalized medicine rises, so does the need for drug discovery and developments in the biotechnology industry fuel market expansion in the region. The Asia-Pacific area has the largest pharmaceutical sector, and a wealth of technologically advanced medical devices that may be easily accessed by producers of proteomics-based goods.

Region with highest CAGR:

North America commanded highest CAGR throughout the domination period due to the development of structure-based drug design, expansion of omics research, desire for high-quality research tools for data reproducibility, and focus on the creation of personalized treatments. Partnerships and collaborations among significant businesses in this region are also helping to expand this industry. Furthermore, in order to accelerate the characterisation and quality monitoring of complex therapeutic proteins, Thermo Fisher Scientific Inc. and Symphogen developed a proven platform process.

Key players in the market:

Some of the key players in Proteomics Market include: Agilent Technologies, inc., Illumina, Inc., Ge Healthcare, Bio - Rad Laboratories, Inc., Bruker Corporation, Thermo fisher Scientific, Inc., Promega Corporation , F.Hoffmann-La Roche Ltd., Danaher, Merck Kgaa., Waters Corporation, Caprion Proteomics Inc., Luminex Corporation, PerkinElmer, Inc., SomaLogic Operating Co. and Olink.

Key Developments:

In February 2023, Waters Corporation acquired Wyatt Technology, which enhances the portfolio of Separation and Detection, which provides customers with an unmatched set of analytical solutions across a wide range of applications.

In October 2022, Agilent Technologies Inc. and CMP Scientific Corp. entered into a co-marketing agreement to provide an integrated capillary electrophoresis-mass spectrometry (CE-MS) solution for the life science and pharmaceutical industries.

In August 2022, Bruker Corporation introduced the new nano Elute 2 nano-LC, MetaboScape, and TASQ software to promote the study of protein-protein interaction and metaproteomics applications. These products also support fluxomics and the most recent developments in PaSER intelligent acquisition.

Products Covered:

  • Reagents & Consumables
  • Instruments
  • Services

Services & Softwares Covered:

  • Core Proteomics Services
  • Bioinformatics Services & Software

Technologies Covered:

  • Spectroscopy
  • Chromatography
  • Electrophoresis
  • Protein Microarrays
  • X-Ray Crystallography
  • Surface Plasmon Resonance
  • Protein Fractionation
  • Other Technologies

Applications Covered:

  • Clinical Diagnosis
  • Clinical Research
  • Drug Discovery
  • Other Applications

End Users Covered:

  • Laboratories
  • Academic & Research Institute
  • Hospitals
  • Pharmaceutical & Biopharmaceutical Companies
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Proteomics Market, By Product

  • 5.1 Introduction
  • 5.2 Reagents & Consumables
  • 5.3 Instruments
  • 5.4 Services

6 Global Proteomics Market, By Services & Software

  • 6.1 Introduction
  • 6.2 Core Proteomics Services
    • 6.2.1 Protein Characterization Services
    • 6.2.2 Protein Identification Services
    • 6.2.3 Protein Purification Services
    • 6.2.4 Quantitative Proteomics Services
    • 6.2.5 Protein Seqencing Services
    • 6.2.6 Protein Separation Services
    • 6.2.7 Custom Assay Services
  • 6.3 Bioinformatics Services & Software
    • 6.3.1 Bioinformatics Tools
    • 6.3.2 Bioinformatics Services
    • 6.3.3 Bioinformatics Databases

7 Global Proteomics Market, By Technology

  • 7.1 Introduction
  • 7.2 Spectroscopy
    • 7.2.1 Mass Spectroscopy
  • 72.2 Nuclear Magnetic Resonance Spectroscopy
    • 7.2.2 Circular Dichroism Spectroscopy
  • 7.3 Chromatography
    • 7.3.1 High Performance Liquid Chromatography
    • 7.3.2 Supercritical Fluid Chromatography
    • 7.3.3 Affinity Chromatography
    • 7.3.4 Ion Chromatography
  • 7.4 Electrophoresis
    • 7.4.1 Gel Electrophoresis
    • 7.4.2 Capillary Electrophoresis
  • 7.5 Protein Microarrays
    • 7.5.1 Biochips
      • 7.5.1.1 Lab-On-Chips
      • 7.5.1.2 Protein Chips
    • 7.5.2 Microarray Instruments
      • 7.5.2.1 Integrated Systems
      • 7.5.2.2 Arrayers
      • 7.5.2.3 Microarray Scanners
  • 7.6 X-Ray Crystallography
  • 7.7 Surface Plasmon Resonance
  • 7.8 Protein Fractionation
  • 7.9 Other Technologies

8 Global Proteomics Market, By Application

  • 8.1 Introduction
  • 8.2 Clinical Diagnosis
    • 8.2.1 Infectious Diseases
    • 8.2.2 Cancer
    • 8.2.3 Diabetes
    • 8.2.4 Autoimmune Diseases
    • 8.2.5 Neurological Disorders
    • 8.2.6 Cardiovascular Diseases
    • 8.2.7 Other Clinical Diagnostic Application
  • 8.3 Clinical Research
  • 8.4 Drug Discovery
    • 8.4.1 Target Discovery
    • 8.4.2 Lead Optimization
    • 8.4.3 Lead Identification
    • 8.4.4 Preclinical Studies
  • 8.5 Other Applications

9 Global Proteomics Market, By End User

  • 9.1 Introduction
  • 9.2 Laboratories
  • 9.3 Academic & Research Institute
  • 9.4 Hospitals
  • 9.5 Pharmaceutical & Biopharmaceutical Companies
  • 9.6 Other End Users

10 Global Proteomics Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Agilent Technologies, inc.
  • 12.2 Illumina, Inc.
  • 12.3 Ge Healthcare
  • 12.4 Bio - Rad Laboratories, Inc.
  • 12.5 Bruker Corporation
  • 12.6 Thermo fisher Scientific, Inc.
  • 12.7 Promega Corporation
  • 12.8 F. Hoffmann-La Roche Ltd.
  • 12.9 Danaher
  • 12.10 Merck Kgaa.
  • 12.11 Waters Corporation
  • 12.12 Caprion Proteomics Inc.
  • 12.13 Luminex Corporation
  • 12.14 PerkinElmer, Inc.
  • 12.15 SomaLogic Operating Co.
  • 12.16 Olink

List of Tables

  • Table 1 Global Proteomics Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Proteomics Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Proteomics Market Outlook, By Reagents & Consumables (2021-2030) ($MN)
  • Table 4 Global Proteomics Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 5 Global Proteomics Market Outlook, By Services (2021-2030) ($MN)
  • Table 6 Global Proteomics Market Outlook, By Services & Software (2021-2030) ($MN)
  • Table 7 Global Proteomics Market Outlook, By Core Proteomics Services (2021-2030) ($MN)
  • Table 8 Global Proteomics Market Outlook, By Protein Characterization Services (2021-2030) ($MN)
  • Table 9 Global Proteomics Market Outlook, By Protein Identification Services (2021-2030) ($MN)
  • Table 10 Global Proteomics Market Outlook, By Protein Purification Services (2021-2030) ($MN)
  • Table 11 Global Proteomics Market Outlook, By Quantitative Proteomics Services (2021-2030) ($MN)
  • Table 12 Global Proteomics Market Outlook, By Protein Seqencing Services (2021-2030) ($MN)
  • Table 13 Global Proteomics Market Outlook, By Protein Separation Services (2021-2030) ($MN)
  • Table 14 Global Proteomics Market Outlook, By Custom Assay Services (2021-2030) ($MN)
  • Table 15 Global Proteomics Market Outlook, By Bioinformatics Services & Software (2021-2030) ($MN)
  • Table 16 Global Proteomics Market Outlook, By Bioinformatics Tools (2021-2030) ($MN)
  • Table 17 Global Proteomics Market Outlook, By Bioinformatics Services (2021-2030) ($MN)
  • Table 18 Global Proteomics Market Outlook, By Bioinformatics Databases (2021-2030) ($MN)
  • Table 19 Global Proteomics Market Outlook, By Technology (2021-2030) ($MN)
  • Table 20 Global Proteomics Market Outlook, By Spectroscopy (2021-2030) ($MN)
  • Table 21 Global Proteomics Market Outlook, By Mass Spectroscopy (2021-2030) ($MN)
  • Table 22 Global Proteomics Market Outlook, By Nuclear Magnetic Resonance Spectroscopy (2021-2030) ($MN)
  • Table 23 Global Proteomics Market Outlook, By Circular Dichroism Spectroscopy (2021-2030) ($MN)
  • Table 24 Global Proteomics Market Outlook, By Chromatography (2021-2030) ($MN)
  • Table 25 Global Proteomics Market Outlook, By High Performance Liquid Chromatography (2021-2030) ($MN)
  • Table 26 Global Proteomics Market Outlook, By Supercritical Fluid Chromatography (2021-2030) ($MN)
  • Table 27 Global Proteomics Market Outlook, By Affinity Chromatography (2021-2030) ($MN)
  • Table 28 Global Proteomics Market Outlook, By Ion Chromatography (2021-2030) ($MN)
  • Table 29 Global Proteomics Market Outlook, By Electrophoresis (2021-2030) ($MN)
  • Table 30 Global Proteomics Market Outlook, By Gel Electrophoresis (2021-2030) ($MN)
  • Table 31 Global Proteomics Market Outlook, By Capillary Electrophoresis (2021-2030) ($MN)
  • Table 32 Global Proteomics Market Outlook, By Protein Microarrays (2021-2030) ($MN)
  • Table 33 Global Proteomics Market Outlook, By Biochips (2021-2030) ($MN)
  • Table 34 Global Proteomics Market Outlook, By Microarray Instruments (2021-2030) ($MN)
  • Table 35 Global Proteomics Market Outlook, By X-Ray Crystallography (2021-2030) ($MN)
  • Table 36 Global Proteomics Market Outlook, By Surface Plasmon Resonance (2021-2030) ($MN)
  • Table 37 Global Proteomics Market Outlook, By Protein Fractionation (2021-2030) ($MN)
  • Table 38 Global Proteomics Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 39 Global Proteomics Market Outlook, By Application (2021-2030) ($MN)
  • Table 40 Global Proteomics Market Outlook, By Clinical Diagnosis (2021-2030) ($MN)
  • Table 41 Global Proteomics Market Outlook, By Infectious Diseases (2021-2030) ($MN)
  • Table 42 Global Proteomics Market Outlook, By Cancer (2021-2030) ($MN)
  • Table 43 Global Proteomics Market Outlook, By Diabetes (2021-2030) ($MN)
  • Table 44 Global Proteomics Market Outlook, By Autoimmune Diseases (2021-2030) ($MN)
  • Table 45 Global Proteomics Market Outlook, By Neurological Disorders (2021-2030) ($MN)
  • Table 46 Global Proteomics Market Outlook, By Cardiovascular Diseases (2021-2030) ($MN)
  • Table 47 Global Proteomics Market Outlook, By Other Clinical Diagnostic Application (2021-2030) ($MN)
  • Table 48 Global Proteomics Market Outlook, By Clinical Research (2021-2030) ($MN)
  • Table 49 Global Proteomics Market Outlook, By Drug Discovery (2021-2030) ($MN)
  • Table 50 Global Proteomics Market Outlook, By Target Discovery (2021-2030) ($MN)
  • Table 51 Global Proteomics Market Outlook, By Lead Optimization (2021-2030) ($MN)
  • Table 52 Global Proteomics Market Outlook, By Lead Identification (2021-2030) ($MN)
  • Table 53 Global Proteomics Market Outlook, By Preclinical Studies (2021-2030) ($MN)
  • Table 54 Global Proteomics Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 55 Global Proteomics Market Outlook, By End User (2021-2030) ($MN)
  • Table 56 Global Proteomics Market Outlook, By Laboratories (2021-2030) ($MN)
  • Table 57 Global Proteomics Market Outlook, By Academic & Research Institute (2021-2030) ($MN)
  • Table 58 Global Proteomics Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 59 Global Proteomics Market Outlook, By Pharmaceutical & Biopharmaceutical Companies (2021-2030) ($MN)
  • Table 60 Global Proteomics Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.